The emerging new arthritis drugs. A clinician's opinion.
In the face of deficiencies in our present system of introducing new drugs, clinicians must be committed to monitoring patients carefully. They must not be caught up in the hyperbole and excitement of the latest new drug, but instead should allow the crucible of time to teach them and the rest of the medical community the ultimate truths about this drug in all situations. They must not let the package circular be their only guide to therapy, for it reflects only what has been accomplished under limited conditions. By knowing their patients well and by learning to proficiently use selected drugs that they have become familiar and comfortable with, conscientious practitioners will approach the present state of the art in meeting the needs of their patients.